Evidence map›Paper›PMID 36872380›Full record

ReviewEuropean journal of pediatrics2023

Assessment of quality of life after laparoscopic GERD surgery in children: a prospective study.

Aurore Haffreingue, Claire Dupont-Lucas, Nathan Dolet, Jean-Baptiste Marret, Thierry Petit, Julien Rod

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aurore HaffreingueDepartment of Pediatric Surgery, Caen University Hospital, Université de Caen Normandie, UFR Médecine, Avenue de La Côte de Nacre, F-14000, Caen, France. aurore.haffreingue@gmail.com.ORCID http://orcid.org/0000-0002-4652-3777
Claire Dupont-LucasDepartment of Pediatric Gastroenterology, Caen University Hospital, Université de Caen Normandie, UFR Médecine, F-14000, Caen, France.
Nathan DoletDepartment of Pediatric Surgery, Caen University Hospital, Université de Caen Normandie, UFR Médecine, Avenue de La Côte de Nacre, F-14000, Caen, France.
Jean-Baptiste MarretDepartment of Pediatric Surgery, Caen University Hospital, Université de Caen Normandie, UFR Médecine, Avenue de La Côte de Nacre, F-14000, Caen, France.
Thierry PetitDepartment of Pediatric Surgery, Caen University Hospital, Université de Caen Normandie, UFR Médecine, Avenue de La Côte de Nacre, F-14000, Caen, France.
Julien RodDepartment of Pediatric Surgery, Caen University Hospital, Université de Caen Normandie, UFR Médecine, Avenue de La Côte de Nacre, F-14000, Caen, France.
Centre Hospitalier Universitaire de Caen Normandie · FRInstitut d’Hématologie et d’Oncologie Pédiatrique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to assess quality of life (QoL) after laparoscopic anti-reflux surgery (LARS) in children with gastroesophageal reflux disease (GERD) and to evaluate GERD symptoms and their impact on daily life and school. From June 2016 to June 2019, all children with GERD from 2 to 16 years of age, without neurologic impairment or malformation-related reflux, were prospectively included in a monocentric study. Patients (or their parents according to the age of the child) answered the Pediatric Questionnaire on Gastroesophageal Symptoms and QoL (PGSQ) before surgery and 3 and 12 months after surgery. Variables were compared by paired, bilateral Student t-test. Twenty-eight children (16 boys) were included. The median age at surgery was 77 months (IQR: 59.2-137) with median weight of 22 kg (IQR: 19.8-42.3). All had a laparoscopic Toupet fundoplication. Median duration of follow-up was 14.7 months (IQR: 12.3-22.5). One patient (4%) had a recurrence of GERD symptoms without abnormalities on follow-up examinations. Preoperative total PGSQ score was 1.42 (± 0.7) and decreased significantly 3 months (0.56 ± 0.6; p < 0.001) and 12 months after surgery (0.34 ± 0.4; p < 0.001). PGSQ subscale analysis revealed a significant decrease at 3 and 12 months for GERD symptoms (p < 0.001), impact on daily life (p < 0.001), and impact on school (p = 0.03).

conclusionThere was a significant improvement in symptoms and their frequency after LARS in children, as well as an improvement of QoL, in the short and medium term. The impact of GERD should be taken into consideration in the treatment decision, given that surgery clearly improves the QoL. WHAT IS KNOWN: • Laparoscopic anti-reflux surgery (LARS) is an established and effective treatment option in pediatric patients with severe GERD refractory to medical treatment. • Effect of LARS on the quality of life (QoL) has been mainly investigated in the adult population but there is very little data on the effect of LARS on the QoL in pediatric patients. WHAT IS NEW: • Our prospective study was the first to analyze the effect of LARS on QoL in pediatric patients without neurologic impairment using validated questionnaires at two postoperative time points with a significant improvement in postoperative QoL at 3 and 12 months. • Our study emphasizes the importance of evaluating QoL and impact of GERD on all the aspects of daily life and of taking these into consideration in the treatment decision.

Indexed as

Gastroesophageal RefluxLaparoscopyNervous System DiseasesAdultChildChild, PreschoolHumansInfantMaleProspective StudiesQuality of LifeTreatment OutcomeChildrenGastroesophageal refluxGERD surgeryLaparoscopic fundoplicationPGSQQuality of life

Identifiers

PMID36872380
OpenAlexW4323270427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.